Sinobioway Group Co.,Ltd.,founded in 1992,is one of the three main industrial groups affiliated with Peking University.
Sinobioway Group is mainly engaged in bioeconomy system establishment and bio-industry development. It primarily invests in biomedicine, bioagriculture, bioenergy, bioenvironment, bioservices, biomanufacturing and biointelligence. The company has become a flagship enterprise in China's bioindustry and has the potential to become one of the most competitive groups in the world!
In respect of biomedicine industry, Sinobioway Group has established 8 manufacturing bases, the products covering many therapeutic fields includes vaccine, cytokines, Monoclonal Antibody drugs.
No.1 Sinobioway Biomedicine Co., Ltd. (Sinobioway Medicine)
Sinobioway Medicine,founded in December 1998, is a research-driven biopharmaceutical company located in PKU Biopark, Xiamen, Fujian province, China, which covers an area of 100,000 square meters. Sinobioway Medicine is the manufacturing base of mouse Nerve Growth Factor with production capacity of 10 million vials per year. Mouse Nerve Growth Factor for Injection is the first therapeutic drug for neural injury in the world and the first finding awarded Nobel Prize in Physiology or Medicines that has been marketed by Chinese. In October 2015, the company has completed a backdoor listing,the stock code is 002581.
No.2 Sinovac Biotech Co., Ltd.
Sinovac is first Chinese vaccine company NASDAQ listed. The company engaged in the development and production of human-used vaccines and animal vaccine. Over the past two decades, the company have successful launch inactivated Hepatitis A Vaccine, Hepatitis A and Hepatitis B Combined Vaccine, Inactivated Influenza Vaccine, inactivated H1N1 Influenza A Vaccine, inactivated Enterovirus Type 71 Vaccine.
No.3 Tianjin Sinobioway Biomedicine Co., Ltd.
Tianjin Sinobioway is the manufacture base of recombinant Human Interferon alpha 2b, covering various dosage forms including Alfaron lyophilized powder, Alfaron solution in vial, Alfaron solution in prefilled syringes and Jaferon® sprays with an annual capacity of 20 million pcs.
No.4 JS Bioway Pharmaceutical Co., Ltd.
JS Bioway is a company focusing on the production and sale of recombinant human insulin and its analogs. The construction plan of the company has two phases, which will achieve the yield target of 5000KG of insulin API and 200 million of insulin finished products. The construction of first-phase plant has been finalized and the yield of insulin API could reach to 1500KG.
No.5 Anhui Sinobioway Medicine Co., Ltd.
Anhui Sinobioway will be built into the manufacture base of antibody drug. The item understudied is Basiliximab, Alemtuzumab, Recombinant humanized anti-CD3 monoclonal antibody injection, Adalimumab, anti-AXL antibody, anti-LAG-3 antibody, LUNX, EpCAM, Trop-2 and C-Met-Adriamycin conjugate antibody-drug.
No.6 Sinobioway Hygene Biopharm Co., Ltd.
Hygene Biopharm is the manufacture base of recombinant human growth hormone. The companys production capacity has reached 6 million vials per year.
No.7 Shenzhen Sinobioway Xinpeng Biomedcine Co., Ltd.
Shenzhen Sinobioway is the manufacture base of recombinant Human Granulocyte Colony-stimulating and recombinant human erythropoietin.
No.8 Bam Biotech CO.,Ltd.
Bam Biotech is focus on the development and manufacturing of custom peptides.The company has supplied over 10,000 peptides to dozens of pharmaceutical companies, biotechnology companies, and other scientific research institutions which come from over 20 countries or regions.
